Regulatory Issues
ACR® is committed to representing and communicating radiologists’ perspectives to the executive branch of the U.S. government.
Artificial Intelligence and Digital Health
ACR advocates radiology’s perspective to the federal government with respect to artificial intelligence (AI) and digital health policy issues, including advocating for AI safety and effectiveness, technology innovation and data sharing.
AI Safety, Effectiveness and Quality Use
- ACR comments to Congress in response to a Cures 2.0 RFI (Aug. 2, 2024)
- ACR comments to Congress regarding the state of AI in healthcare (May 6, 2024)
- ACR comments to Senate HELP Minority AI White Paper and RFC (Sept. 22, 2023)
- ACR comments on FDA Draft Guidance: AI Predetermined Change Control Plans (July 31, 2023)
- ACR comments on FDA Draft Guidance: Breakthrough Devices Program (Dec. 15, 2022)
- ACR comments on HHS OCR-CMS NPRM: Algorithm Use Nondiscrimination, ACA Sec. 1557 (Sept. 28, 2022)
Advancing Technology Innovation
Data Sharing and Interoperability
- ACR comments on ONC NPRM: Interoperability, Information Blocking Updates (Sep. 25, 2024)
- ACR comments on CMS-ONC NPRM: Information Blocking Disincentives (Jan. 2, 2024)
- ACR comments on ONC NPRM: Interoperability (HTI-1) (June 20, 2023)
- ACR comments on Proposed Changes to HIPAA Rule (March 15, 2021)
Other Digital Health
Radiation Safety and Medical Use
ACR advocates radiology’s perspective to the federal government on medical radiation safety issues, such radiological materials licensing, authorized use, and drug/device oversight and availability to patients.
Radiological Materials Licensing and Medical Use
Nuclear Medicine Extravasation Reporting to Government
- ACR letter to NRC on draft proposed rule vote (Oct. 3, 2024)
- ACR letter to Congress opposing extravasation dosimetry mandate bill (May 28, 2024)
- ACR comments on NRC proposed rule, Extravasation as Medical Events (Sept. 1, 2023)
- ACR comments on Extravasation (Aug. 31, 2022)
Federal Appropriations
ACR advocates for the highest possible funding levels for radiology and imaging related research to ensure medical progress and advancements in the field. Support for radiology research, including a wide range of diagnostics, treatments, and therapeutics are shared with congressional and government leaders, along with academic and research policies.
National Research Strategy
- ACR comments to Senator Cassidy's NIH Modernization RFI (Oct. 27, 2023)
- ACR letter of support for Dr. Bertagnolli to serve as NIH Director (Sept. 25, 2023)
- ACR comments on NIBIB RFI: 2024–2028 Strategic Plan Framework (July 17, 2023)
Funding for Radiology Research Innovation
Public Health and Population Screening
ACR advocates radiology’s perspective to the federal government concerning radiology related public health concerns, including population screening, guidelines and programs.
Cancer Screening
- ACR comments on HRSA supported breast cancer recommendations (Nov. 19, 2024)
Patient Accessibility
For older public record documents from ACR to federal agencies please refer to regulations.gov, or contact Michael Peters, Senior Director, Government Affairs, or Katie Grady, Government Affairs Director.